What is the current Intra-Abdominal Pressure Measurement Devices Market size?

The Intra-Abdominal Pressure Measurement Devices Market is projected to register a CAGR of 8.20% during the forecast period (2024-2029) Read More

Who are the key players in Intra-Abdominal Pressure Measurement Devices Market?

Becton, Dickinson and Company , ConvaTec Inc. , Spiegelberg GmbH , Medline Industries and Potrero Medical are the major companies operating in the Intra-Abdominal Pressure Measurement Devices Market. Read More

Which is the fastest growing region in Intra-Abdominal Pressure Measurement Devices Market?

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029). Read More

Which region has the biggest share in Intra-Abdominal Pressure Measurement Devices Market?

In 2024, the North America accounts for the largest market share in Intra-Abdominal Pressure Measurement Devices Market. Read More

What years does this Intra-Abdominal Pressure Measurement Devices Market cover?

The report covers the Intra-Abdominal Pressure Measurement Devices Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Intra-Abdominal Pressure Measurement Devices Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Intra-Abdominal Pressure Measurement Devices Market Trends

Market Trends of Intra-Abdominal Pressure Measurement Devices Industry

This section covers the major market trends shaping the Intra-Abdominal Pressure Measurement Devices Market according to our research experts:

Hospital Segment is Anticipated to Hold a Significant Share in the Global Intra-Abdominal Pressure Measurement Devices Market Over the Forecast Period

Factors such as technological advancements and prolonged hospital stays are anticipated to promote the market over the forecast period. For instance, according to an article published in April 2022 in PubMed, IAH is a significant and independent predictor of short- and long-term mortality, as well as severe organ failure and a prolonged hospital stay. Furthermore, as per an article published in May 2021 in Sage Journal, IAH is associated with acute renal outcomes in ICU and non-ICU patients. Hence, hospital systems typically use IAH measurement devices on patients undergoing surgery or therapy for chronic conditions to provide better care for their patients. As a result, this can boost the IAP measurement device segment growth over the forecast period.
As the number of hospitals increases, the demand for IAH devices increases, thereby driving the overall market growth over the forecast period. Hence, considering the risk of developing IAP in ICU-admitted patients and the increase in technological advancements in IAP measurement devices, the use of IAP measurement devices in hospitals is likely to increase, thereby boosting the market segment growth over the forecast period.
For instance, according to the AHA hospital statistics for 2022, the United States has 6,093 hospitals, and the total number of admissions to all US hospitals is projected to be 33,356,853 in 2022. Hence, as the number of hospital admissions increases, ICU units are likely to be in demand for IAP measurement devices, which is anticipated to boost market growth during the forecast period.
Factors such as technological advancements and prolonged hospital stays are anticipated to promote the market during the forecast period. For instance, according to an article published in April 2022 in PubMed, IAH is a significant and independent predictor of short- and long-term mortality, as well can cause organ failure and lead to a prolonged hospital stay. Furthermore, as per an article published in May 2021 in Sage Journal, IAH is associated with acute renal outcomes in ICU and non-ICU patients. Hence, hospital systems typically use IAH measurement devices on patients undergoing surgery or therapy for chronic conditions to provide better care for their patients. As a result, this can boost the IAP measurement device segment growth during the forecast period.
As the number of hospitals increases, the demand for IAH measurement devices increases, thereby driving the overall market growth during the forecast period. Furthermore, according to the American Hospital Association (AHA) hospital statistics for 2022, the United States has 6,093 hospitals, and the total number of admissions to all US hospitals is projected to be 33,356,853 in 2022. Therefore, as hospital admissions rise, ICU units are likely to need IAP measurement devices, which is expected to fuel market growth for IAP measurement devices during the the forecast period.
Furthermore, according to the 2022 report from the American Cancer Society (ACS), kidney cancer is among the ten most common cancers in both men and women. The same source estimated that in 2022 there would likely be 28,710 cases of kidney cancer in women and 50,290 cases in men. Overall, the lifetime risk for developing kidney cancer in men is about 1 in 46 (2.02%). The lifetime risk for women is about 1 in 80 (1.03%). Therefore, IAH is more likely to develop in people who have high-risk kidney problems, which is expected to result in hospitalization, hence, accelerating the IAP measurement devices market growth during the forecast period
Hence, considering the risk of developing IAP in ICU-admitted patients and the increase in technological advancements in IAP measurement devices, the use of IAP measurement devices in hospitals is likely to increase, thereby boosting the market segment growth during the forecast period.

Intra-Abdominal Pressure Measurement Devices Market : Estimated Number of Kidney Cancer Cases, (in Thousand), United States, 2022

Understand The Key Trends Shaping This Market

Download PDF

North America is Expected to Witness a Growth in the Intra-Abdominal Pressure Measurement Devices Market Over the Forecast Period

North America is expected to witness growth in the intra-abdominal pressure measurement devices market owing to the rapid rise in the number of hospitals and ambulatory surgical centers, adoption of advanced medical technologies, surge in cases of chronic diseases, and prevalence of intra-abdominal hypertension.
Intra-abdominal hypertension (IAH) and abdominal compartment syndrome (ACS) are two complications that intensive care unit (ICU) patients potentially experience. All bodily systems, particularly the cardiovascular, respiratory, renal, and neurological systems, are impacted by ACS and IAH. Hence, the rise in chronic diseases in the North American region can create demand for the IAP devices market. For instance, according to the International Agency for Research on Cancer (IARC) estimations, the number of people affected with Kidney cancer is anticipated to be 10,030 by 2040 in Canada.
Digital IAP monitoring devices are now commonly used in the ICU to continuously monitor patients who do not require doctors to monitor them. Hence, digitalizing IAP monitoring devices will propel the IAP measurement devices market forward. For instance, a case study published in the OTA journal in June 2022 showed how the MY01 (NXTSENS, Montreal, Canada) is a minimally invasive device that can accurately and continuously measure changes in intra-compartmental pressure.
The management of ACS in level 1 trauma facilities and rural places where continuous clinical monitoring is not possible is significantly impacted by preliminary clinical data. Finally, continuous ICP monitoring has the potential to be a valuable tool for both traumatologists and trauma patients. Similarly, the availability and use of innovative instruments such as digital pressure monitors are expected to increase demand for compartment syndrome measurement devices in the near future.
As a result of the increase in the number of hospitals and ambulatory surgical centers, the adoption of advanced medical technologies, high prevalence of intra-abdominal hypertension, North America is expected to witness growth in the IAP measurement devices market during the forecast period.